{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:40:14Z","timestamp":1791751214951,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008788","name":"College of Veterinary Medicine, Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007520","name":"Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jpeds.2026.114993","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:41:11Z","timestamp":1768664471000},"page":"114993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Duration of Antibiotic Therapy for Gram-Negative Bloodstream Infections in the Neonatal Intensive Care Unit"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-7581","authenticated-orcid":false,"given":"Colleen J.","family":"Djordjevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Magers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Cantey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Prusakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo J.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2026.114993_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.0593","article-title":"Early-Onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies","volume":"174","author":"Stoll","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2026.114993_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100727","article-title":"A global point prevalence survey of antimicrobial use in neonatal intensive care units: the no-more-antibiotics and resistance (NO-MAS-R) study","volume":"32","author":"Prusakov","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jpeds.2026.114993_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107158","article-title":"Prospective antimicrobial stewardship interventions by multidisciplinary teams to reduce neonatal antibiotic use in South Africa: the Neonatal Antimicrobial Stewardship (NeoAMS) study","volume":"146","author":"Dramowski","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jpeds.2026.114993_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jpc.16647","article-title":"Efficacy of short-course antibiotics for culture-positive neonatal sepsis: a systematic review and meta-analysis","volume":"60","author":"Singh","year":"2024","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2026.114993_bib5","series-title":"Red book: 2024-2027 Report of the Committee on infectious diseases","first-page":"365","article-title":"Serious neonatal bacterial infections caused by Enterobacterales (including septicemia and meningitis)","author":"Pediatrics","year":"2024"},{"key":"10.1016\/j.jpeds.2026.114993_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpeds.2018.07.036","article-title":"Early antibiotic exposure and adverse outcomes in preterm, very low birth weight infants","volume":"203","author":"Cantey","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.114993_bib8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1055\/s-0038-1632390","article-title":"Association of Antibiotic utilization and neurodevelopmental outcomes among extremely low gestational age neonates without proven sepsis or necrotizing enterocolitis","volume":"35","author":"Ting","year":"2018","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jpeds.2026.114993_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1542\/peds.2007-3423","article-title":"Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants","volume":"123","author":"Cotten","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.114993_bib10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jpeds.2011.05.033","article-title":"Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants","volume":"159","author":"Kuppala","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.114993_bib11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2286","article-title":"Duration of initial empirical antibiotic therapy and outcomes in very low birth weight infants","volume":"143","author":"Ting","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.114993_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2026.114993_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.siny.2016.12.001","article-title":"Acute kidney injury in the fetus and neonate","volume":"22","author":"Nada","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.jpeds.2026.114993_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052360","article-title":"Safety and efficacy of Nafcillin for empiric therapy of late-onset sepsis in the NICU","volume":"149","author":"Magers","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.114993_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/INF.0b013e3182011d12","article-title":"Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit","volume":"30","author":"Chiu","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2026.114993_bib16","series-title":"Nelson's neonatal antimicrobial therapy","year":"2024"},{"key":"10.1016\/j.jpeds.2026.114993_bib17","doi-asserted-by":"crossref","DOI":"10.4414\/SMW.2022.w30195","article-title":"Retrospective data analysis for definition of multidrug resistance in gram-negative bacteria - a consensus proposal","volume":"152","author":"Friedli","year":"2022","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jpeds.2026.114993_bib18","first-page":"275","article-title":"Society for Healthcare Epidemiology of America and infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals","volume":"18","author":"Shlaes","year":"1997","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jpeds.2026.114993_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/INF.0000000000003314","article-title":"Duration of antibiotic therapy in neonatal gram-negative bacterial Sepsis-10 days versus 14 days: a randomized controlled trial","volume":"41","author":"Fursule","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2026.114993_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/tropej\/fmq012","article-title":"Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis","volume":"56","author":"Gathwala","year":"2010","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jpeds.2026.114993_bib21","first-page":"8","article-title":"Ten days versus fourteen days antibiotic therapy in culture proven neonatal sepsis: single Center Egyptian experience","volume":"17","author":"Salama","year":"2020","journal-title":"Pediatr Oncall J"},{"key":"10.1016\/j.jpeds.2026.114993_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12098-021-03794-6","article-title":"Ten versus 14 days of antibiotic therapy in culture-proven neonatal sepsis: a randomized, controlled trial","volume":"89","author":"Reddy","year":"2022","journal-title":"Indian J Pediatr"},{"issue":"6","key":"10.1016\/j.jpeds.2026.114993_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/tropej\/fmad036","article-title":"Ten- vs. 14-day antibiotic therapy for culture-positive neonatal sepsis","volume":"69","author":"Islam","year":"2023","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jpeds.2026.114993_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jpc.13518","article-title":"Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: a randomised controlled trial","volume":"53","author":"Rohatgi","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2026.114993_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/tropej\/fml054","article-title":"Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis","volume":"52","author":"Chowdhary","year":"2006","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jpeds.2026.114993_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10096-019-03467-5","article-title":"Short- versus long-course therapy in gram-negative bacilli bloodstream infections","volume":"38","author":"Sousa","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jpeds.2026.114993_bib27","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cmi.2018.01.013","article-title":"Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study","volume":"24","author":"Giannella","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jpeds.2026.114993_bib28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s15010-017-1020-5","article-title":"Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections","volume":"45","author":"Nelson","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.jpeds.2026.114993_bib29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"392","author":"BALANCE Investigators","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2026.114993_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(00)90015-1","article-title":"An antibiotic policy to prevent emergence of resistant bacilli","volume":"355","author":"de Man","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2026.114993_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jamapediatrics.2020.4719","article-title":"Antibiotic susceptibility of Escherichia coli among infants admitted to neonatal intensive care units across the US from 2009 to 2017","volume":"175","author":"Flannery","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2026.114993_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41372-023-01634-3","article-title":"Short-course empiric antibiotic therapy for possible early-onset sepsis in the NICU","volume":"43","author":"Sanchez","year":"2023","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2026.114993_bib33","first-page":"227","article-title":"Gram-Negative Bacilli in infants hospitalized in the neonatal intensive care unit","volume":"6","author":"Patel","year":"2017","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.jpeds.2026.114993_bib34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1542\/peds.2005-2677","article-title":"The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants","volume":"118","author":"Cotten","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.114993_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1542\/peds.2005-0179","article-title":"Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death","volume":"117","author":"Clark","year":"2006","journal-title":"Pediatrics"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:16:44Z","timestamp":1781943404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347626000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"alternative-id":["S0022347626000211"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.114993","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of Antibiotic Therapy for Gram-Negative Bloodstream Infections in the Neonatal Intensive Care Unit","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.114993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114993"}}